Skip to main content

Main menu

  • Content
    • Current Issue
    • Advance Access
    • Archive
    • Supplements
    • Special Collections
    • Topic Collections
  • For Authors
    • Instructions for Authors
    • Tips for Writing About Programs in GHSP
      • Local Voices Webinar
      • Connecting Creators and Users of Knowledge
    • Submit Manuscript
    • Publish a Supplement
    • Promote Your Article
    • Resources for Writing Journal Articles
  • About
    • About GHSP
    • Editorial Team
    • Advisory Board
    • FAQs
    • Instructions for Reviewers

User menu

  • My Alerts

Search

  • Advanced search
Global Health: Science and Practice
  • My Alerts

Global Health: Science and Practice

Dedicated to what works in global health programs

Advanced Search

  • Content
    • Current Issue
    • Advance Access
    • Archive
    • Supplements
    • Special Collections
    • Topic Collections
  • For Authors
    • Instructions for Authors
    • Tips for Writing About Programs in GHSP
    • Submit Manuscript
    • Publish a Supplement
    • Promote Your Article
    • Resources for Writing Journal Articles
  • About
    • About GHSP
    • Editorial Team
    • Advisory Board
    • FAQs
    • Instructions for Reviewers
  • Alerts
  • Find GHSP on LinkedIn
  • Visit GHSP on Facebook
  • RSS

Latest Articles

  • You have access
    A better future for injectable contraception?
    Global Health: Science and Practice December 2014, 2(4):378-380; https://doi.org/10.9745/GHSP-D-14-00158
    • Provision of injectables though drug shops appears practicable and can contribute a marked share of family planning services.

    • A potential longer-acting injectable providing at least 6 months of protection appeals to programmatic professionals.

    • Subcutaneous administration of DMPA offers major injectable improvements over the current intramuscular approach.

    • Ironically, while injectable use will inevitably grow, better choice and wider availability of other methods—especially of long-acting and permanent methods—will reduce injectables′ overall share.

  • You have access
    Policy and programmatic considerations for introducing a longer-acting injectable contraceptive: perspectives of stakeholders from Kenya and Rwanda
    Kevin McKenna, Jennet Arcara, Kate H Rademacher, Caroline Mackenzie, Fidele Ngabo, Emmanuel Munyambanza, Jennifer Wesson and Elizabeth E Tolley
    Global Health: Science and Practice December 2014, 2(4):459-471; https://doi.org/10.9745/GHSP-D-14-00106

    Unique attributes of a longer-acting injectable would likely appeal to both existing injectable users and new clients, both for spacing and for limiting births, and allow health systems to operate more efficiently. Considerations for enhancing successful introduction of this potential new method include keeping the cost low, expanding access through community-based distribution, and training providers to improve practices about injectables in general.

  • You have access
    Caution on corticosteroids for preterm delivery: learning from missteps
    Stephen Hodgins
    Global Health: Science and Practice December 2014, 2(4):371-373; https://doi.org/10.9745/GHSP-D-14-00197

    An important new study in lower-level health facilities in low- and middle-income countries found an increased risk of neonatal deaths with corticosteroid use in pregnant women with imminent preterm birth, in contrast with the positive results previously found in high-income countries. The surprising finding demonstrates that context matters. The increase appears largely due to steroids administered in cases that were not actually preterm, probably due to inaccurate pregnancy dating and challenges with diagnostic capacity. Promoting public health often requires decisions based on less-than-perfect evidence, but we must be vigilant about gathering and assessing new evidence and ready to change strategies.

  • You have access
    Maternal mental health in Amhara region, Ethiopia: a cross-sectional survey
    Joy Noel Baumgartner, Angela Parcesepe, Yared Getachew Mekuria, Dereje Birhanu Abitew, Wondimu Gebeyehu, Francis Okello and Dominick Shattuck
    Global Health: Science and Practice December 2014, 2(4):482-486; https://doi.org/10.9745/GHSP-D-14-00119

    Poor mental health, including suicidal thoughts, affects a substantial proportion of surveyed women who are up to 2 years postpartum in the Amhara region of Ethiopia. Opportunities for integrating basic psychosocial mental health services into maternal and child health services should be explored.

  • You have access
    It's not Ebola … it's the systems
    Victor K Barbiero
    Global Health: Science and Practice December 2014, 2(4):374-375; https://doi.org/10.9745/GHSP-D-14-00186

    The 2014 Ebola outbreak in West Africa demonstrates key deficiencies in investment in health systems. Despite some modest investment in health systems, our field has instead largely chosen to pursue shorter-term, vertical efforts to more rapidly address key global health issues such as smallpox, polio, malaria, and HIV/AIDS. While those efforts have yielded substantial benefits, we have paid a price for the lack of investments in general systems strengthening. The Ebola deaths we have seen represent a small portion of deaths from many other causes resulting from weak systems. Major systems strengthening including crucial nonclinical elements will not happen overnight but should proceed in a prioritized, systematic way.

  • You have access
    Breaking new ground in family planning communication
    Global Health: Science and Practice December 2014, 2(4):376-377; https://doi.org/10.9745/GHSP-D-14-00192

    The Urban Reproductive Health Initiative has shown impact on contraceptive use from its communication components even within a few years, as described in 2 GHSP articles. One specifically addressed “ideation” about family planning in detail and was able to show both changes in ideation due to program exposure and correlated changes in contraceptive use. The other used a sophisticated analytical technique that indicated the observed changes in contraceptive use resulted from exposure to the communication efforts, and not just because people more prone to adopt family planning were also more likely to recall exposure to the communication messages.

  • You have access
    Strategies to reduce risks in ARV supply chains in the developing world
    Chris Larson, Robert Burn, Anja Minnick-Sakal, Meaghan O'Keefe Douglas and Joel Kuritsky
    Global Health: Science and Practice December 2014, 2(4):395-402; https://doi.org/10.9745/GHSP-D-14-00105

    Key strategies of the main ARV procurement program for PEPFAR to reduce supply chain risks include: (1) employing pooled procurement to reduce procurement and shipping costs and to accommodate changing country needs by making stock adjustments at the regional level, and (2) establishing regional distribution centers to facilitate faster turnaround of orders within defined catchment areas.

  • Open Access
    Reaching out to a community to improve maternal health in Ghana: the story of one midwife
    John Kuumuori Ganle
    Global Health: Science and Practice August 2014, 2(3):366-369; https://doi.org/10.9745/GHSP-D-14-00110
  • Open Access
    Major challenges to scale up of visual inspection-based cervical cancer prevention programs: the experience of Guatemalan NGOs
    Anita Nandkumar Chary and Peter J Rohloff
    Global Health: Science and Practice August 2014, 2(3):307-317; https://doi.org/10.9745/GHSP-D-14-00073

    Scale up of visual inspection with acetic acid (VIA) in Guatemala encountered major challenges, including high attrition of people trained, didactic training without hands-on skills building, lack of continued supervision, and provision of VIA alone without immediate on-site provision of cryotherapy.

  • Open Access
    Exclusive breastfeeding: aligning the indicator with the goal
    Thomas W Pullum
    Global Health: Science and Practice August 2014, 2(3):355-356; https://doi.org/10.9745/GHSP-D-14-00061

    While the global objective is exclusive breastfeeding (EBF) for a full 6 months duration, the standard indicator is a “prevalence” indicator, that is, the percentage of all children under age 6 months who are exclusively breastfed at a point in time. That yields a higher percentage than a more direct indicator of duration and can be easily misunderstood, exaggerating the amount of EBF. A measurement of actual percentage of children exclusively breastfeeding for a full 6 months can be easily calculated from standard DHS and MICS data.

Pages

  • Previous
  • Next
  • 1
  • …
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • …
  • 111
Back to top
Johns Hopkins Center for Communication Programs

Follow Us On

  • LinkedIn
  • Facebook
  • RSS

Articles

  • Current Issue
  • Advance Access Articles
  • Past Issues
  • Topic Collections
  • Most Read Articles
  • Supplements

More Information

  • Submit a Paper
  • Instructions for Authors
  • Instructions for Reviewers

About

  • About GHSP
  • Advisory Board
  • FAQs
  • Privacy Policy
  • Contact Us

© 2026 Creative Commons Attribution 4.0 International License. ISSN: 2169-575X

Powered by HighWire